PharmaMax Co-Investment Fund, LP — Form D/A
PharmaMax Co-Investment Fund, LP of STAMFORD, CT, a pooled investment fund, filed a Form D amendment with the SEC on 2015-04-15. The offering totals $9.2M, of which $9.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2015-04-15
- Form: D/A
- Accession: 0001618634-15-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $9.2M
- Amount sold: $9.2M
- Minimum investment: $10K
- Investors: 25
- Date of first sale: 2014-05-13
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-224252
Issuer
- Name: PharmaMax Co-Investment Fund, LP
- CIK: 0001618634
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1266 EAST MAIN STREET, STAMFORD, CT, 06902
- Phone: 8187319742
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Joseph T Draper | Executive Officer | Stamford, CT |
| Pacific Advantage Group Ltd. | Executive Officer | Stamford, CT |
| Don John Odell | Executive Officer | Stamford, CT |
| James W White, Jr. | Executive Officer | Stamford, CT |
| David John Zezza | Executive Officer | New York, NY |
| PharmaMax Co-Investment GP, LP | Promoter | Stamford, CT |
| John David Zezza | Executive Officer | Darien, CT |
Other filings by this issuer (1)
More